Pharma-Bio Serv (PBSV) EPS (Weighted Average and Diluted) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -38.71% |
| Oct 31, 2025 | -26.79% |
| Jul 31, 2025 | -21.43% |
| Apr 30, 2025 | -33.11% |
| Jan 31, 2025 | -56.13% |
| Jul 31, 2024 | -5.64% |
| Apr 30, 2024 | -18.06% |
| Oct 31, 2023 | -18.73% |
| Jul 31, 2023 | -6.48% |
| Apr 30, 2023 | 37.59% |
| Jan 31, 2023 | 16.67% |
| Oct 31, 2022 | 18.41% |
| Jul 31, 2022 | 30.51% |
| Apr 30, 2022 | 22.38% |
| Jan 31, 2022 | 22.69% |
| Oct 31, 2021 | -57.08% |
| Jul 31, 2021 | 78.97% |
| Apr 30, 2021 | 38.97% |
| Jan 31, 2021 | -5.07% |
| Oct 31, 2020 | -22.21% |
| Jul 31, 2020 | 9.60% |
| Apr 30, 2020 | 14.30% |
| Jan 31, 2020 | 13.24% |
| Jul 31, 2019 | -5.84% |
| Apr 30, 2019 | 17.28% |
| Oct 31, 2018 | -35.61% |
| Jul 31, 2018 | -9.44% |
| Apr 30, 2018 | -16.01% |
| Jan 31, 2018 | -35.10% |
| Oct 31, 2017 | -20.11% |
| Jul 31, 2017 | -16.27% |
| Apr 30, 2017 | -17.81% |
| Jan 31, 2017 | -18.53% |
| Oct 31, 2016 | -21.16% |
| Jul 31, 2016 | -15.88% |
| Apr 30, 2016 | -37.52% |
| Jan 31, 2016 | -1.28% |
| Oct 31, 2015 | 19.57% |
| Jul 31, 2015 | 30.60% |